Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Ferrante

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Cardiology|March 21, 2017
Radiation dose among different cardiac and vascular invasive procedures: The RODEO studyAlessandro Sciahbasi, Giuseppe Ferrante, Dionigi Fischetti, et al.
European Heart Journal|November 6, 2009
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-studyPeter Barlis, Evelyn Regar, Patrick W Serruys, et al.
Cancers|January 23, 2024
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline RoundAlberto Antonicelli, Piergiorgio Muriana, Giovanni Favaro, et al.
Cardiovascular Research|July 9, 2020
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomographyGiuseppe Ferrante, Fabio Fazzari, Ottavia Cozzi, et al.
Cardiovascular Diabetology|February 7, 2023
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trialMauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2016
Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trialsNicole Ferko, Giuseppe Ferrante, James T Hasegawa, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 7, 2023
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study designFrancesco Cannata, Giulio Stefanini, Carmelo Carlo-Stella, et al.
International Journal of Cardiology|July 27, 2018
Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysisEliano P Navarese, Bernhard Wernly, Michael Lichtenauer, et al.
Open Heart|November 10, 2025
Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunctionLaura Novelli, Jorge Sanz-Sanchez, Alessandra Iaccarino, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology|March 21, 2017
Radiation dose among different cardiac and vascular invasive procedures: The RODEO studyAlessandro Sciahbasi, Giuseppe Ferrante, Dionigi Fischetti, et al.
European Heart Journal|November 6, 2009
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-studyPeter Barlis, Evelyn Regar, Patrick W Serruys, et al.
Cancers|January 23, 2024
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline RoundAlberto Antonicelli, Piergiorgio Muriana, Giovanni Favaro, et al.
Cardiovascular Research|July 9, 2020
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomographyGiuseppe Ferrante, Fabio Fazzari, Ottavia Cozzi, et al.
Cardiovascular Diabetology|February 7, 2023
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trialMauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 17, 2016
Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trialsNicole Ferko, Giuseppe Ferrante, James T Hasegawa, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 7, 2023
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study designFrancesco Cannata, Giulio Stefanini, Carmelo Carlo-Stella, et al.
International Journal of Cardiology|July 27, 2018
Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysisEliano P Navarese, Bernhard Wernly, Michael Lichtenauer, et al.
Open Heart|November 10, 2025
Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunctionLaura Novelli, Jorge Sanz-Sanchez, Alessandra Iaccarino, et al.
Pageof 9